Resultados da busca - Yoshiki Arakawa
- Mostrando 1 - 20 resultados de 34
- Ir para a próxima página
-
1
-
2
-
3
-
4
F11-Mediated Inhibition of RhoA Signalling Enhances the Spread of Vaccinia Virus In Vitro and In Vivo in an Intranasal Mouse Model of Infection por João V. Cordeiro, Susana Guerra, Yoshiki Arakawa, Mark P. Dodding, Mariano Estéban, Michael Way
Publicado em 2009Artigo -
5
Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution por Kengo Ogura, Takashi Mizowaki, Yoshiki Arakawa, Masakazu Ogura, Katsuyuki Sakanaka, Susumu Miyamoto, Masahiro Hiraoka
Publicado em 2013Artigo -
6
Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell‐derived neural precursors por Masaomi Koyanagi, Jun Takahashi, Yoshiki Arakawa, Daisuke Doi, Hitoshi Fukuda, Hideki Hayashi, Shuh Narumiya, Nobuo Hashimoto
Publicado em 2007Artigo -
7
In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion por Eishu Hirata, Hiroko Yukinaga, Yuji Kamioka, Yoshiki Arakawa, Susumu Miyamoto, Takaharu Okada, Erik Sahai, Michiyuki Matsuda
Publicado em 2012Artigo -
8
-
9
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study por Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori
Publicado em 2023Artigo -
10
Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neurons por Yoshiki Arakawa, Haruhiko Bito, Tomoyuki Furuyashiki, Takahiro Tsuji, Sayaka Takemoto‐Kimura, Kazuhiro Kimura, Kazuhiko Nozaki, Nobuo Hashimoto, Shuh Narumiya
Publicado em 2003Artigo -
11
Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma por Shoichi Deguchi, Fumiharu Ohka, Yoshiki Shiba, Junya Yamaguchi, Aya Sato, Keiko Shinjo, Yoshiki Arakawa, Yoshitaka Narita, Yutaka Kondo, Ryuta Saito
Publicado em 2025Artigo -
12
Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination por Nakao Ota, Masahiko Itani, Tomohiro Aoki, Aki Sakurai, Takashi X. Fujisawa, Yasuaki Okada, Kosumo Noda, Yoshiki Arakawa, Sadahisa Tokuda, Rokuya Tanikawa
Publicado em 2025Artigo -
13
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan por Toshihiko Iuchi, Akihiro Inoue, Yuichi Hirose, Motohiro Morioka, Keishi Horiguchi, Atsushi Natsume, Yoshiki Arakawa, Koichi Iwasaki, Minoru Fujiki, Toshihiro Kumabe, Yukinori Sakata
Publicado em 2022Artigo -
14
Dummy run study for outlining and plan quality of intensity-modulated radiotherapy in elderly patients with newly diagnosed glioblastoma: The Japan clinical oncology group study JC... por Tomohiro Ono, Megumi Uto, Yohei Mineharu, Yoshiki Arakawa, Mitsuhiro Nakamura, Teiji Nishio, Hiroshi Igaki, Keiji Nihei, Satoshi Ishikura, Yoshitaka Narita, Takashi Mizowaki
Publicado em 2025Artigo -
15
ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts por Takahiro Tsuji, Toshimasa Ishizaki, Muneo Okamoto, Chiharu Higashida, Kazuhiro Kimura, Tomoyuki Furuyashiki, Yoshiki Arakawa, Raymond B. Birge, Tetsuya Nakamoto, Hisamaru Hirai, Shuh Narumiya
Publicado em 2002Artigo -
16
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma por Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa
Publicado em 2024Artigo -
17
Intraoperative dorsal language network mapping by using single‐pulse electrical stimulation por Yukihiro Yamao, Riki Matsumoto, Takeharu Kunieda, Yoshiki Arakawa, Katsuya Kobayashi, Kiyohide Usami, Sumiya Shibata, Takayuki Kikuchi, Nobukatsu Sawamoto, Nobuhiro Mikuni, Akio Ikeda, Hidenao Fukuyama, Susumu Miyamoto
Publicado em 2014Artigo -
18
High programmed cell death 1 ligand–1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma por Daiki Murata, Yohei Mineharu, Yoshiki Arakawa, Bin Liu, Masahiro Tanji, Yamaguchi Makoto, Koichi Fujimoto, Nobuyuki Fukui, Yukinori Terada, Ryuta Yokogawa, Maki Yamaguchi, Sachiko Minamiguchi, Susumu Miyamoto
Publicado em 2017Artigo -
19
Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma por Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Junsaku Kitagawa, Arata Aoi, Ryo Nishikawa
Publicado em 2020Artigo -
20
The Rho-mDia1 Pathway Regulates Cell Polarity and Focal Adhesion Turnover in Migrating Cells through Mobilizing Apc and c-Src por Norikazu Yamana, Yoshiki Arakawa, Tomohiro Nishino, Kazuo Kurokawa, Masahiro Tanji, Reina E. Itoh, James Monypenny, Toshimasa Ishizaki, Haruhiko Bito, Kazuhiko Nozaki, Nobuo Hashimoto, Michiyuki Matsuda, Shuh Narumiya
Publicado em 2006Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Biology
Cancer research
Biochemistry
Cell biology
Gene
Oncology
Cell
Chemotherapy
Pathology
Glioma
Signal transduction
Genetics
Neuroscience
Radiation therapy
Surgery
Adverse effect
Clinical trial
Cytoskeleton
Glioblastoma
Actin
CDC42
Disease
Physics
RHOA
Radiology
Actin cytoskeleton
Chemistry
Clinical endpoint